Science for living: Can using AI risk prediction in breast cancer screening improve early detection?Science for living: Can using AI risk prediction in breast cancer screening improve early detection?
Artificial intelligence is transforming medicine, but what does that mean for breast cancer screening? Researchers at UMass Chan Medical School are exploring how an AI-based tool might help identify women at higher risk for breast cancer and in doing so, detect cancers that standard mammograms might miss.
Study shows exercise during chemotherapy for breast cancer measurably improves quality of lifeStudy shows exercise during chemotherapy for breast cancer measurably improves quality of life
For many women with breast cancer, the very treatment that saves their lives can also bring fatigue, loss of muscle mass, emotional strain and other daunting obstacles. A new study shows that exercise during chemotherapy does more than rebuild strength—it measurably improves quality of life while treatment is underway, helping women feel better physically, emotionally and mentally during one of the most demanding chapters of care.
New GLP-1 pill helps patients lose up to 8% of body weight, trial showsNew GLP-1 pill helps patients lose up to 8% of body weight, trial shows
Orforglipron led to greater weight loss than semaglutide tablets and could offer more effective oral alternative to jabs A new daily pill could be a more effective GLP-1 tablet for weight loss, according to a clinical trial that may pave the way for an improved non-injection alternative to Wegovy and Mounjaro. The drug, called orforglipron Read More
New GLP-1 pill orforglipron outperforms oral semaglutide in yearlong diabetes trialNew GLP-1 pill orforglipron outperforms oral semaglutide in yearlong diabetes trial
A novel GLP-1 receptor agonist (RA) pill called orforglipron leads to a larger reduction in blood sugar levels after a year than the current available oral GLP-1 RA (semaglutide), finds a phase 3 randomized controlled trial published in The Lancet. Additionally, participants taking orforglipron had significantly greater reductions in body weight than those taking oral Read More
GLP-1 drugs combined with healthy lifestyle habits linked to reduced cardiovascular risk among diabetes patientsGLP-1 drugs combined with healthy lifestyle habits linked to reduced cardiovascular risk among diabetes patients
Individuals living with type 2 diabetes (T2D) had a significantly lower risk of poor cardiovascular health when they used a GLP-1 receptor agonist (GLP-1 RA) in combination with adhering to healthy lifestyle habits, according to a new study led by researchers at Harvard T.H. Chan School of Public Health and the Department of Veterans Affairs Read More
GLP-1 drugs combined with healthy lifestyle habits linked with reduced cardiovascular risk among diabetes patientsGLP-1 drugs combined with healthy lifestyle habits linked with reduced cardiovascular risk among diabetes patients
Home Chronic Diseases GLP-1 drugs combined with healthy lifestyle habits linked with reduced cardiovascular risk among diabetes patients By Maya Brownstein February 25, 2026 Hide caption Show caption aprott / iStock Jump to Section Share Post LinkedIn Facebook WhatsApp Email Copy link For immediate release: February 25, 2026 Boston, MA—Individuals living with type 2 diabetes Read More
‘Father Knows Best’ star Lauren Chapin dead at 80 after 5-year cancer battle’Father Knows Best’ star Lauren Chapin dead at 80 after 5-year cancer battle
Lauren Chapin, the beloved “Father Knows Best” star who played Kathy “Kitten” Anderson, has died at age 80 after a five-year cancer battle, her son announced.
Semaglutide Not Linked to Depression Symptoms in People With HIVSemaglutide Not Linked to Depression Symptoms in People With HIV
(MedPage Today) — DENVER — People with HIV didn’t have a significant rise in depressive symptoms after starting semaglutide (Ozempic, Wegovy, Rybelsus) for diabetes or weight loss, according to a nine-site observational study. After a median… (MedPage Today) — DENVER — People with HIV didn’t have a significant rise in depressive symptoms after starting Read More
How an anti-obesity drug improves metabolism beyond weight lossHow an anti-obesity drug improves metabolism beyond weight loss
Tirzepatide is one of the drugs that has revolutionized the treatment of obesity and other conditions such as diabetes in recent years. Despite its clinical success, its precise molecular and cellular mechanisms are still not fully understood. A study in mice shows that the drug has a direct impact on improving metabolism by activating brown adipose tissue, a type of fat specialized in energy expenditure.
Novo Nordisk to slash Wegovy and Ozempic prices starting in 2027Novo Nordisk to slash Wegovy and Ozempic prices starting in 2027
Starting in 2027, the Danish pharma firm will sell its weight-loss and diabetes drugs for $675 per month. Starting in 2027, the Danish pharma firm will sell its weight-loss and diabetes drugs for $675 per month.